Apim Therapeutics raised €2.7M in a funding round in Apr 2017. The company is based in Trondheim, Norway. Investors in the round: Investinor, Rune Rinnan, Trond Mohn. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
